Compound Detail
CHEMBL5426073
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5426073 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OWRZWTYYHCTHDB-FQEVSTJZSA-N |
3
Targets
6
Activities
2
Assay Types
14
PK Parameters
12
Publications
0
Known Names
Molecular Properties
411.5
MW (Da)
3.99
ALogP
3
HBA
2
HBD
74.4
PSA (Ų)
0.54
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Kd 4 meas. best 6.72
EC50 2 meas. best 7.79
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HT-29 CHEMBL384 | EC50 | 7.79 | 7.79 | 16.2 | 2 |
| Receptor-interacting serine/threonine-protein kinase 1 CHEMBL5464 | Kd | 6.72 | 6.72 | 190.0 | 2 |
| Receptor-interacting serine/threonine-protein kinase 3 CHEMBL1795199 | Kd | 5.81 | 5.715 | 1535.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 25127.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 25324.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 13732.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 148.0 | mL.min-1.g-1 | Mus musculus |
| CL | 131.0 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 31.0 | mL.min-1.g-1 | Canis lupus familiaris |
| Cmax | 5232.59 | nM | Rattus norvegicus |
| F | 36.9 | % | Rattus norvegicus |
| MRT | 10.2 | hr | Rattus norvegicus |
| T1/2 | 0.1558 | hr | Mus musculus |
| T1/2 | 0.1767 | hr | Rattus norvegicus |
| T1/2 | 0.745 | hr | Canis lupus familiaris |
| T1/2 | 6.11 | hr | Rattus norvegicus |
| Tmax | 6.0 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-29 | EC50 | = | 16.17 | nM | 7.79 | Anti-necroptotic activity against TSZ induced necroptosis in human HT-29 cells p... | 37364415 |
| HT-29 | EC50 | = | 16.17 | nM | 7.79 | Anti-necroptosis activity against human HT-29 cell assessed as inhibition of TSZ... | 38484677 |
| Receptor-interacting serine/threonine-protein kinase 1 | Kd | = | 190.0 | nM | 6.72 | Binding affinity to RIPK1 (unknown origin) | 37364415 |
| Receptor-interacting serine/threonine-protein kinase 1 | Kd | = | 190.0 | nM | 6.72 | Binding affinity to RIP1 (unknown origin) assessed as dissociation constant by K... | 38484677 |
| Receptor-interacting serine/threonine-protein kinase 3 | Kd | = | 1535.0 | nM | 5.81 | Binding affinity to RIP3 (unknown origin) assessed as dissociation constant by K... | 38484677 |
| Receptor-interacting serine/threonine-protein kinase 3 | Kd | = | 2400.0 | nM | 5.62 | Binding affinity to RIPK3 (unknown origin) | 37364415 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38484677 | 10.1016/j.ejmech.2024.116304 | ADMET | 16 |
| 37364415 | 10.1016/j.bmc.2023.117385 | HT-29 | 4 |
| 37364415 | 10.1016/j.bmc.2023.117385 | Mus musculus | 4 |
| 37364415 | 10.1016/j.bmc.2023.117385 | Receptor-interacting serine/threonine-protein kinase 3 | 3 |
| 37364415 | 10.1016/j.bmc.2023.117385 | Receptor-interacting serine/threonine-protein kinase 1 | 3 |
| 37364415 | 10.1016/j.bmc.2023.117385 | Unchecked | 2 |
| 37364415 | 10.1016/j.bmc.2023.117385 | Mixed lineage kinase domain-like protein | 2 |
| 38484677 | 10.1016/j.ejmech.2024.116304 | HT-29 | 2 |
| 37364415 | 10.1016/j.bmc.2023.117385 | U-937 | 1 |
| 38484677 | 10.1016/j.ejmech.2024.116304 | Receptor-interacting serine/threonine-protein kinase 1 | 1 |
| 38484677 | 10.1016/j.ejmech.2024.116304 | Receptor-interacting serine/threonine-protein kinase 3 | 1 |
| 38484677 | 10.1016/j.ejmech.2024.116304 | Mus musculus | 1 |
Data from ChEMBL 36 via Core Engine